Myths About Silicone Breast Implants

Silicone breast implant decisions deserve more than reassurance or alarm. The useful question is not whether implants are simply "safe" or "dangerous." It is whether you understand the known risks, the uncertain areas, the monitoring plan, and the possibility of future surgery.

The U.S. Food and Drug Administration provides current patient information and requires a boxed warning and patient decision checklist for breast implants. Use the labeling for the exact device you are considering.

Myth: FDA approval means there are no important risks

FDA approval does not make an implant risk-free. Possible complications include capsular contracture, pain, changes in sensation, infection, asymmetry, rupture, additional surgery, and removal. Some outcomes can be permanent.

Ask the surgeon to review the manufacturer labeling and patient decision checklist with you. The discussion should cover both common complications and rare but serious risks.

Myth: Breast implants are lifetime devices

Breast implants are not lifetime devices. The chance of a complication increases with time, and some people need one or more later operations. No one can predict the exact date when an implant will need revision, replacement, or removal.

Future care can include examinations, imaging, and surgery. Those practical and financial needs belong in the original decision.

Myth: You will always know if a silicone implant ruptures

A silicone gel implant rupture can be silent. The breast may not look or feel different. The FDA recommends ultrasound or MRI monitoring for silicone gel implants according to the device labeling and clinical findings.

Mammography remains important for routine breast cancer screening, but it is not the main test for silent silicone rupture. Tell the imaging facility that you have implants and follow the screening plan from your health care team.

Myth: A rupture never needs attention

Silicone gel may remain within the scar capsule after rupture, or it may move outside the capsule. A confirmed or suspected rupture needs clinical evaluation. The right response depends on symptoms, imaging, implant condition, and the surgical findings.

Contact a clinician for a new shape change, firmness, pain, swelling, mass, or another implant concern. Do not rely on a myth that every rupture is either an emergency or harmless.

Myth: Systemic symptoms are fully explained

Some patients report fatigue, memory or concentration problems, joint and muscle pain, rash, hair loss, anxiety, depression, and other systemic symptoms that they associate with breast implants. The term breast implant illness, or BII, is often used for this group of concerns.

The FDA says BII is not a formal diagnosis and does not have specific diagnostic tests or recognized criteria. The cause and degree of association with implants remain unclear. Symptoms still deserve a complete medical evaluation and a careful discussion of implant options.

Myth: All breast implant cancer risks are the same

Breast implant-associated anaplastic large cell lymphoma, or BIA-ALCL, is a lymphoma that develops in the fluid or scar capsule around an implant. It occurs more often in people with textured implants than in those with smooth implants. The FDA has also received reports of squamous cell carcinoma and other lymphomas in the capsule.

Persistent swelling, a mass, or pain around an implant needs prompt evaluation. Ask which implant surface is being considered and how implant-specific risks affect the plan.

Myth: One implant creates one predictable look

Silicone implants come in different widths, profiles, volumes, and gel characteristics. The result also depends on your tissue, skin, chest width, breast position, implant placement, and healing. A device cannot guarantee a cup size, softness, symmetry, or another person's result.

The useful comparison connects implant dimensions and tradeoffs to your anatomy and the shape you want.

Bring these questions to the consultation

• Which exact implant and surface are you recommending, and why?
• May I review the manufacturer labeling and patient decision checklist?
• How do my tissue and anatomy affect the plan?
• What are the main short-term and long-term risks?
• What imaging and routine breast screening will I need?
• Which symptoms or breast changes should prompt a call?
• How would revision, replacement, or removal affect the breast later?

Learn more about breast augmentation in Bend, Oregon, or book a consultation with Dr. Borsting to compare implant choices and long-term care.